Remission in Psoriatic Arthritis

被引：14

作者：

Caperon, Anna ^{[1
]}

Helliwell, Philip S. ^{[1
]}

机构：

[1] Univ Leeds, Sect Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England

来源：

JOURNAL OF RHEUMATOLOGY | 2012年 / 39卷

关键词：

PSORIATIC ARTHRITIS; PSORIASIS; OUTCOME MEASURES; LOW DISEASE ACTIVITY; REMISSION; MINIMAL DISEASE-ACTIVITY; RHEUMATOID-ARTHRITIS; PRELIMINARY DEFINITION; CRITERIA; PERFORMANCE; DRUGS; SCORE;

D O I：

10.3899/jrheum.120235

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Psoriatic arthritis (PsA) is a multifaceted disease that challenges outcome methodologists. A number of measures have been used to define remission in PsA but they have been mostly articular. Composite measures of disease activity and low disease states are now emerging, but further work is required to assess the implications of achieving these goals and to develop cost-effective treatment strategies to achieve them. (J Rheumatol 2012;39 Suppl 89:19-21; doi:10.3899/jrheum.120235)

引用

页码：19 / 21

页数：3

共 20 条

[1] Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs [J].

Cantini, F. ;

Niccoli, L. ;

Nannini, C. ;

Cassara, E. ;

Pasquetti, P. ;

Olivieri, I. ;

Salvarani, C. .

RHEUMATOLOGY, 2008, 47 (06) :872-876

[2] Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment [J].

Coates, L. C. ;

Fransen, J. ;

Helliwell, P. S. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) :48-53

[3]

Coates LC, 2011, J RHEUMATOL, V38, P1496, DOI [10.3899/jrheum.101119, 10.3899/jrheum.101114, 10.3899/jrheum.110278, 10.3899/jrheum.101116]

[4] Validation of Minimal Disease Activity Criteria for Psoriatic Arthritis Using Interventional Trial Data [J].

Coates, Laura C. ;

Helliwell, Philip S. .

ARTHRITIS CARE & RESEARCH, 2010, 62 (07) :965-969

[5] AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID-ARTHRITIS [J].

FELSON, DT ;

ANDERSON, JJ ;

BOERS, M ;

BOMBARDIER, C ;

FURST, D ;

GOLDSMITH, C ;

KATZ, LM ;

LIGHTFOOT, R ;

PAULUS, H ;

STRAND, V ;

TUGWELL, P ;

WEINBLATT, M ;

WILLIAMS, HJ ;

WOLFE, F ;

KIESZAK, S .

ARTHRITIS AND RHEUMATISM, 1995, 38 (06) :727-735

[6] Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors [J].

Fransen, J. ;

Antoni, C. ;

Mease, P. J. ;

Uter, W. ;

Kavanaugh, A. ;

Kalden, J. R. ;

Van Riel, P. L. C. M. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (10) :1373-1378

[7]

Gladman DD, 2001, J RHEUMATOL, V28, P1045

[8] European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies [J].

Gossec, L. ;

Smolen, J. S. ;

Gaujoux-Viala, C. ;

Ash, Z. ;

Marzo-Ortega, H. ;

van der Heijde, D. ;

FitzGerald, O. ;

Aletaha, D. ;

Balint, P. ;

Boumpas, D. ;

Braun, J. ;

Breedveld, F. C. ;

Burmester, G. ;

Canete, J. D. ;

de Wit, M. ;

Dagfinrud, H. ;

de Vlam, K. ;

Dougados, M. ;

Helliwell, P. ;

Kavanaugh, A. ;

Kvien, T. K. ;

Landewe, R. ;

Luger, T. ;

Maccarone, M. ;

McGonagle, D. ;

McHugh, N. ;

McInnes, I. B. ;

Ritchlin, C. ;

Sieper, J. ;

Tak, P. P. ;

Valesini, G. ;

Vencovsky, J. ;

Winthrop, K. L. ;

Zink, A. ;

Emery, P. .

ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (01) :4-12

[9] The comparative one-year performance of anti-tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis:: Results from a longitudinal, observational, multicenter study [J].

Heiberg, Marte Schrumpf ;

Koldingsnes, Wenche ;

Mikkelsen, Knut ;

Rodevand, Erik ;

Kaufmann, Cecilie ;

Mowinckel, Petter ;

Kvien, Tore K. .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (02) :234-240

[10]

Helliwell Philip S, 2012, J Rheumatol, V39, P398, DOI 10.3899/jrheum.111233

← 1 2 →